Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma.

Shoji K, Murayama T, Mimura I, Wada T, Kume H, Goto A, Ohse T, Tanaka T, Inagi R, van der Hoorn FA, Manabe I, Homma Y, Fukayama M, Sakurai T, Hasegawa T, Aburatani H, Kodama T, Nangaku M.

Am J Pathol. 2013 Jun;182(6):2191-203. doi: 10.1016/j.ajpath.2013.02.024. Epub 2013 Apr 17.

PMID:
23602831
[PubMed - indexed for MEDLINE]
Free Article
2.

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.

PMID:
18094421
[PubMed - indexed for MEDLINE]
Free Article
3.

Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro.

Knaup KX, Monti J, Hackenbeck T, Jobst-Schwan T, Klanke B, Schietke RE, Wacker I, Behrens J, Amann K, Eckardt KU, Warnecke C, Wiesener MS.

Mol Carcinog. 2013 Jul 2. doi: 10.1002/mc.22065. [Epub ahead of print]

PMID:
23818324
[PubMed - as supplied by publisher]
4.

Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H, Choo-Wing R, Bellinger G, Tsukazawa KS, Brown V, Signoretti S, Soltoff SP, Cantley LC.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3483-8. doi: 10.1073/pnas.1222435110. Epub 2013 Feb 1.

PMID:
23378636
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.

Tanaka T, Torigoe T, Hirohashi Y, Sato E, Honma I, Kitamura H, Masumori N, Tsukamoto T, Sato N.

J Cancer Res Clin Oncol. 2014 Mar;140(3):503-13. doi: 10.1007/s00432-014-1593-7. Epub 2014 Jan 30.

PMID:
24477694
[PubMed - indexed for MEDLINE]
6.

The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B.

Clin Cancer Res. 2005 Feb 1;11(3):1129-35.

PMID:
15709180
[PubMed - indexed for MEDLINE]
Free Article
7.

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.

Balamurugan K, Luu VD, Kaufmann MR, Hofmann VS, Boysen G, Barth S, Bordoli MR, Stiehl DP, Moch H, Schraml P, Wenger RH, Camenisch G.

Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.

PMID:
19581925
[PubMed - indexed for MEDLINE]
8.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
[PubMed - indexed for MEDLINE]
9.

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.

Cancer Res. 2001 Jul 1;61(13):5215-22.

PMID:
11431362
[PubMed - indexed for MEDLINE]
Free Article
10.

MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression.

Aubert S, Fauquette V, Hémon B, Lepoivre R, Briez N, Bernard D, Van Seuningen I, Leroy X, Perrais M.

Cancer Res. 2009 Jul 15;69(14):5707-15. doi: 10.1158/0008-5472.CAN-08-4905. Epub 2009 Jun 23.

PMID:
19549898
[PubMed - indexed for MEDLINE]
Free Article
11.

Myoglobin expression in renal cell carcinoma is regulated by hypoxia.

Behnes CL, Bedke J, Schneider S, Küffer S, Strauss A, Bremmer F, Ströbel P, Radzun HJ.

Exp Mol Pathol. 2013 Dec;95(3):307-12. doi: 10.1016/j.yexmp.2013.09.003. Epub 2013 Sep 25.

PMID:
24076247
[PubMed - indexed for MEDLINE]
12.

Identification of novel VHL target genes and relationship to hypoxic response pathways.

Maina EN, Morris MR, Zatyka M, Raval RR, Banks RE, Richards FM, Johnson CM, Maher ER.

Oncogene. 2005 Jun 30;24(28):4549-58.

PMID:
15824735
[PubMed - indexed for MEDLINE]
13.

Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.

Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B.

Eur Urol. 2006 Dec;50(6):1272-7. Epub 2006 Jun 13.

PMID:
16814458
[PubMed - indexed for MEDLINE]
14.
15.

Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.

Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y.

J Pathol. 2005 Feb;205(3):377-87.

PMID:
15682440
[PubMed - indexed for MEDLINE]
16.

Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.

Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B.

BJU Int. 2008 Feb;101(4):480-4. Epub 2007 Oct 8.

PMID:
17922867
[PubMed - indexed for MEDLINE]
17.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
[PubMed - indexed for MEDLINE]
18.

PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.

Petrella BL, Brinckerhoff CE.

Cancer Biol Ther. 2009 Jul;8(14):1389-401. Epub 2009 Jul 30.

PMID:
19483472
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The VHL-dependent regulation of microRNAs in renal cancer.

Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM.

BMC Med. 2010 Oct 21;8:64. doi: 10.1186/1741-7015-8-64.

PMID:
20964835
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM.

Mol Cancer. 2006 Nov 3;5:56.

PMID:
17083723
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk